Virtual screening, molecular docking studies and DFT calculations of FDA approved compounds similar to the non-nucleoside reverse transcriptase inhibitor (NNRTI) efavirenz

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was confirmed as the causative virus of COVID-19 disease, which is currently a worldwide pandemic. Efavirenz, a non-nucleoside reverse transcriptase inhibitor (NNRTI), is one of the most potent chemical compounds proposed to treat COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Jordaan, Maryam A., Ebenezer, Oluwakemi, Damoyi, Nkululeko, Shapi, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418767/
https://www.ncbi.nlm.nih.gov/pubmed/32802982
http://dx.doi.org/10.1016/j.heliyon.2020.e04642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418767/
https://www.ncbi.nlm.nih.gov/pubmed/32802982
http://dx.doi.org/10.1016/j.heliyon.2020.e04642

Ejemplares similares